Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,853 | -29,855 | N/A | N/A | N/A |
| Depreciation Amortization | 1,008 | 860 | N/A | N/A | N/A |
| Other Working Capital | -2,498 | 25,102 | N/A | N/A | N/A |
| Other Operating Activity | 1,009 | -5,752 | 0 | 0 | 0 |
| Operating Cash Flow | $-36,334 | $-9,645 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -590 | -1,509 | N/A | N/A | N/A |
| Investing Cash Flow | $-590 | $-1,509 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 682 | N/A | N/A | N/A | N/A |
| Debt Issued | 2,750 | 4,000 | N/A | N/A | N/A |
| Common Stock Issued | 200,229 | 0 | N/A | N/A | N/A |
| Common Stock Repurchased | -19 | -5 | N/A | N/A | N/A |
| Other Financing Activity | 68,183 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $271,825 | $3,995 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 3,704 | 10,863 | N/A | N/A | N/A |
| End Cash Position | 238,605 | 3,704 | N/A | N/A | N/A |
| Net Cash Flow | $234,901 | $-7,159 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,334 | -9,645 | N/A | N/A | N/A |
| Capital Expenditure | -590 | -1,509 | N/A | N/A | N/A |
| Free Cash Flow | -36,924 | -11,154 | 0 | 0 | 0 |